個股熱度排行 | 1月4日港股盤前
根據uSMART輿情監測數據,從3日晚間到4日港股盤前時間段,市場關注指數最高的2只股票是融創中國、威高股份。
1月4日—港股關注排行TOP2

融創中國

關注度第一爲融創中國,該股上個交易日收盤下跌5.18%,報於4.58港元。近5個交易日累計下跌8.40%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
融創中國出售深圳項目51% 變現近36億人民幣
融創35.8億元人幣出售深圳地皮51%權益 料帳面虧5億、可3年內買回
威高股份

關注度第二爲威高股份,該股上個交易日收盤上漲1.72%,報於13.04港元。近5個交易日累計上漲7.06%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
威高股份:威高骨科擬10.3億元收購威高新生醫療全部股權以擴大其現有客戶羣的產品範圍
四環醫藥附屬吉林惠升生物製藥成功完成A+輪融資;威高股份附屬擬10.3億元收購山東威高新生醫療器械共100%股權
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.